Dr. Stoxx Says Alibaba Is a 'Sell The News' Play

Loading...
Loading...

Dr. Thomas Carr, founder of DrStoxx.com, suggested to Benzinga that investors use Alibaba Group Holding Ltd's BABA earnings report as a "sell the news" play.

Carr noted that last quarter, Alibaba's earnings report fell a nickel short of expectations, causing shares to slide from $120 to a low near $95.

"This time things should be different," Carr told Benzinga via email. "Remember Singles Day? It beat revenue expectations by over $1 billion, with a 60 percent year over year sales growth, which has had the analysts all scrambling to raise consensus targets."

Carr added that Alibaba should easily report a top-line beat, but investors should still pay attention to the firm's monetization rates as there is some concern that it will be lower than it was a quarter a quarter.

Bottom line, "this may be a sell the news play."

In Thursday's premarket, Alibaba reported EPS of $0.81, beating expectations of $0.74.

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorExclusivesAnalyst RatingsDr StoxxDr. Thomas Carr
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...